Clinical Guidelines

Why Early NK Treatment Matters

Recognizing the importance of early treatment strategies in neurotrophic keratitis

Share

Neurotrophic keratitis (NK) is a serious eye condition caused by damage to the trigeminal nerve, leading to significant visual impairment if not recognized early. Prompt diagnosis and treatment escalation are crucial, as patients often present with subtle symptoms. Effective management involves utilizing therapies like cryopreserved amniotic membrane (CAM) and recombinant human nerve growth factor (cenegermin) to enhance corneal nerve regeneration. Clinicians must also navigate challenges such as insurance issues and educate patients regarding long-term care to prevent recurrence.

Original Source(s)

Why Early NK Treatment Matters

Recognizing the importance of early treatment strategies in neurotrophic keratitis

  • by Sean Cushman

  • March 2, 2026

  • 6 min

Related Content

The Ophthalmologist’s Time Machine 38

Glaucoma, eugenics, and Lucien Howe (1848-1928): when the personal became political

National Institutes of Health Builds Digital Model of RPE Cells

AI-driven 3D model maps polarity changes relevant to AMD progression

  • February 27, 2026

  • 2 min
AAO Recap: 3.5-Year Observations from the GATHER2 Open-Label Extension (OLE) Trial

  • February 26, 2026

  • 2 min